Compare FURY & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FURY | LNSR |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Electronics |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.8M | 106.6M |
| IPO Year | 2011 | 2005 |
| Metric | FURY | LNSR |
|---|---|---|
| Price | $0.52 | $6.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $1.90 | ★ $11.33 |
| AVG Volume (30 Days) | ★ 208.2K | 48.4K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | N/A | $4.90 |
| Revenue Next Year | N/A | $18.71 |
| P/E Ratio | ★ N/A | $10.69 |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $0.50 | $4.95 |
| 52 Week High | $1.02 | $12.94 |
| Indicator | FURY | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 37.06 | 33.63 |
| Support Level | $0.51 | $5.34 |
| Resistance Level | $0.57 | $8.73 |
| Average True Range (ATR) | 0.02 | 0.23 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 22.05 | 13.98 |
Fury Gold Mines Ltd is a Canadian-focused high-grade gold exploration company. The company's projects are strategically positioned in two prolific mining regions: the Eeyou Istchee James Bay Region of Quebec and the Kitikmeot Region in Nunavut. Fury Gold's project portfolio comprises the Committee Bay gold project in Nunavut, and the Eau Claire gold, Sakami gold, Elmer East gold and lithium, and Eleonore South gold projects in Quebec. Additionally, it also owns interests in the Kipawa rare earths project and has full ownership of the Zeus heavy rare earths project, both located in the Temiscamingue region of Quebec. The company operates in two reportable segments: Quebec and Nunavut.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.